Click on title to read/print any PDF's below
posted: July 1, 2020
Emergency Order 20-002, which among other things, allows physicians to renew controlled substance prescriptions and medical marijuana certifications for existing patients via telemedicine without having to conduct an in-person physician examination. This Emergency Order was set to expire on April 15th, however, Emergency Order 20-004 extended the order until May 8th. DOH Emergency Order 20-007 was issued by Surgeon General Scott Rivkees and extends Emergency Order 20-002 again, until May 31st, and additionally, DOH Emergency Order 20-009 was issued by Surgeon General Rivkees which again extends Emergency Order 20-002 until June 30th, 2020. Most recently, another DOH Emergency Order was issued this evening by SG Rivkees (DOH EO 20-011) that again extends Emergency Order 20-002 until the expiration of Executive Order 20-52 (State of Emergency), including any extensions thereof.
All of the DOH Emergency Orders mentioned are available below
Rosie Tuzik,Johnson & Blanton, LLC.
Gov't Relations #TeamJB
posted May 29, 2020
updated letter to Govenor DeSantis from FSIPP
posted May 5, 2020
letter to Governor DeSantis from FSIPP
Click to view Letter to Governor DeSantis
posted May 4, 2020
Breaking News from CMS
Great News for Audio Payment Only! In response to the tireless efforts of ASIPP, Community Oncology Alliance (COA), and organized medicine, the Centers for Medicare & Medicaid Services (CMS) announced this afternoon that they will be covering telephone only services at the same rate as in-office services, as we requested in our letter to CMS Administrator, Seema Verma. While this outcome is technically different form our request, it is financially the same.
CMS is increasing payments for audio-only telephone visits between Medicare beneficiaries and their physicians to match payments for similar office and outpatient visits. This would increase payments for these services to $46.19 for 99441 (same as 99212), $76.15 for 99442 (same ad 99213), and $110.43 for 99443 (same as 99214), and the payments are retroactive to March 1, 2020.
This is a major victory for ASIPP, organized medicine, and patients, that will enable IPM to care for their patients, with chronic pain who may not have access to audio-visual technology or high-speed Interne
ASIPP worked with Sen. Bill Cassidy (R-LA), Sen. John Boozman (R-AR), Sen. Mitch McConnell (R-KY), Rep, James Comer (R-KY), Rep. Larry Bucshon (R-IN), Rep. Andy Barr (R-KY), and others, to spearhead this response to our request to CMS. (See April 15 letter to CMS).
CMS may make further continuations to extend this option to August 6.
posted April 3, 2020
FSIPP letter to the Membership
posted April 2, 2020
Small Business help- CARES Act - Paycheck Protection Program
posted: March 24, 2020
North American Neuromodulation Society : COVID-19 and Telemedicine
posted: March 23, 2020
Click on title to read/print any PDF's below
posted: March 19, 2020
Thank you to Mandy Francis ARNP, FSIPP member for sharing this information
the direct link is: https://www.deadiversion.usdoj.gov/coronavirus.html
https://youtu.be/23qT2ZjRWe0 video link
February 2020 Help Us Protect Your Patients
February 2020 Media Release
(click to enlarge and read, or download PDF)
January 2020From: Richard Lawhern MBlackburn@aol.com
I am beginning work on an article explaining the horrific impacts of "high prescriber" letters on chronic pain patients and their doctors. As part of this effort, I've posted a data call on my personal Facebook account, potentially seen by up to 4500 "followers", and in other newsgroups that reach at least that number. In less than 24 hours, I've already gotten responses from across the US that confirm this practice is wide-spread, and is driving more doctors out of pain management under direct threat of DEA or DoJ malicious persecution. It also appears that Medicare and some State authorities are continuing to assert the CDC Guidelines as a hard limit on opioid prescribing, ignoring the "clarifications" published in April 2019 by CDC and FDA.
I welcome any definitive information you can share concerning the prevalence of this practice and its effects on doctors and patients.
September 23, 2019
Dr. Harold Cordner presenting a check from FSIPP in support of ASIPP to Dr. Lax Manchikanti
September 14, 2018
News from the Joint Committee on Controlled Substances 2018 Meeting Minutes - HB 21 Interpretation
Any pain longer than 3-7 days is Non Acute Pain
CLICK HERE FOR the complete FMA Newsletter.
BREAKING NEWS MARCH 29, 2018
CMS proposes to force patients off effective opioid doses without their physician's approval
Centers for Medicare and Medicaid Services (CMS) is proposing a limit on the amount of opioids a physician can prescribe to a patient. This limitation, that may take effect on Jan.1, 2019, would be unrelated to the patient's past experience or need. It would render pharmacists unable to fill prescriptions that CMS has defined as “high” or long-term dosages unless an appeal is approved. CMS defines long-term opioid therapy as opioid use for more than 90 consecutive days and high-dose usage as at least 90 mg morphine equivalent dosage (MED) per day. However, this definition has never received substantial scientific support. The history of dose investigation shows that opinions about what constitutes the appropriate amount of opioids have changed through the years. To begin, a paper published 15 years ago in the New England Journal of Medicine suggested most people do not benefit from opioids administered above 180 mg per day. This article ignited a heated debate. However, it focused on efficacy, not the risk of overdose or addiction at higher doses.
May 8, 2017
PRESS RELEASE: Letter to Governor Rick Scott
Dear Governor Scott,
The Florida Society of Interventional Pain Physicians (FSIPP) would like to thank you for rising to the challenge of combatting the substance abuse and the opioid crisis in the State of Florida. Your unrelenting support of this problem has been much appreciated by the pain management physicians in our State. The task of controlling or eliminating this killer epidemic will not be easy, but we believe you can succeed. Thank you from the families, community, physicians, and others who have been impacted by this crisis.
February 15, 2017
ALERT: Designee Access to E-FORCSE
On February 14, 2017, a designee of a prescriber or dispenser may have direct access to the controlled substance dispensing information in the E-FORCSE® database by registering on the E-FORCSE® secure web portal.
E-FORCSE staff will be hosting two webinars regarding the implementation of designee access, as outlined here.
January 20, 2017
Level II Office Based Florida DOH Certification And Inspection
If you are Level II Office Surgery Certified by the Florida DOH there will be new changes in the inspection process. Please see below communication from Cheryl White, Florida Risk Manager regarding the opportunity for mock inspections, given the new format for certification. Additionally, see attachment.
Dear Office Surgery Administrator,
We would like to offer a Pre-Inspection Consultation prior to your next Office-Based Surgery Inspection. Big Changes have occurred! We are no longer state inspectors. The State of Florida has changed the Office Based Surgery program inspectors. The new inspectors will be from the Investigative Services Unit.
Please see the attached document that shows what we can do to help your office get ready.
Cheryl E. White, RN, BS, MSHL, LNCC, LHRM, MSCC, DFSHRMPS
Sheree M. Saroff, RN, BSN, MBA, LHRM, CLC, MSCC
Harold Cordner, MD
The use of opioids to treat acute and chronic nonmalignant and malignant pain has steadily increased since the late 1990s. With this increase in opioid use, prescription opioid abuse increased to epidemic proportions. In 2012, an estimated 2.1 million Americans suffered through substance-abuse problems related to prescription opioid pain relievers. Florida was the epicenter of prescription-drug abuse, overdose deaths and "pill mills."
Since 2010, the state of Florida has drastically reduced the accidental deaths due to prescription opioid abuse through legislation, the enactment of the Prescription Drug Monitoring Program, the crackdown on pill mills and other means.
FSIPP President Harold L Dalton, DO in attendance.
DEERFIELD BEACH, Fla. —Fear of the DEA has been a recurring theme in the WESH 2 News ongoing investigation of Florida's prescription drug problem. Patients with real health issues are being denied the medication.
The DEA said it would answer those accusations at Florida's Board of Pharmacy hearing Monday.
"We don't want people to fear us, ...
Past webinars are posted on the PAST-EVENTS page
FSIPP has been a leader in promoting fair legislation, access to care and protecting reimbursement. We continue to educate payors, state officials and organizations regarding our area of expertise. We must take ownership of our speciality, promote well developed research and continue to expand our mission in the public and political arena.
To promote the development and practice of safe, high quality, cost-effective interventional pain management techniques for the diagnosis and treatment of pain and related disorders, and to ensure patient access to interventional pain medicine (or management) doctors and these treatments in the State of Florida.
Thank You to Our Current Sponsors
Articles on Genetics Testing in Pain Management
Reserved for those who donate to the FSIPP PAC or to FSIPP.
Our parent organization is ASIPP, the American Society of Interventional Pain Physicians. Visit ASIPPs website, for a bountiful resource for pain practitioners, and to review a list of ASIPPs accomplishments which have greatly benefited both pain patients and pain physicians.